In our research, we hypothesized METTL14 promoted PLAGL2 expression by increasing m6A methylation modification of PLAGL2, activating β-catenin signaling, thereby affecting NSCLC development. This evidence concerns the gene METTL14 and non-small cell lung carcinoma.